The majority (34%) of studies listed the measurement of established markers in routine clinical use, such as insulin resistance, serum oestradiol, liver fat content, and C-reactive protein, as the primary outcome measure (Figure 7A, Table 1 and Table S1). This evidence concerns the gene CRP and Insulin resistance.